S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
S&P 500   4,431.85 (+2.43%)
DOW   34,725.47 (+1.65%)
QQQ   351.80 (+3.14%)
AAPL   170.33 (+6.98%)
MSFT   308.26 (+2.81%)
FB   301.71 (+2.40%)
GOOGL   2,667.02 (+3.37%)
AMZN   2,879.56 (+3.11%)
TSLA   846.35 (+2.08%)
NVDA   228.40 (+4.08%)
BABA   115.23 (+3.08%)
NIO   20.90 (-0.99%)
AMD   105.24 (+2.57%)
CGC   7.27 (+6.13%)
MU   79.27 (+0.70%)
GE   92.10 (+2.45%)
T   25.21 (+4.52%)
F   19.54 (-0.05%)
DIS   138.63 (+2.37%)
AMC   15.06 (+3.72%)
PFE   54.33 (+1.80%)
ACB   3.91 (+3.17%)
BA   190.57 (+0.43%)
OTCMKTS:FSNUY

Fresenius SE & Co. KGaA Stock Forecast, Price & News

$10.39
-0.02 (-0.19%)
(As of 01/28/2022 12:00 AM ET)
Add
Compare
Today's Range
$10.19
$10.39
50-Day Range
$9.39
$10.79
52-Week Range
$9.33
$14.81
Volume
48,913 shs
Average Volume
50,306 shs
Market Capitalization
$23.21 billion
P/E Ratio
11.17
Dividend Yield
1.73%
Beta
1.33
30 days | 90 days | 365 days | Advanced Chart
Receive FSNUY News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.


Fresenius SE & Co. KGaA logo

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, Fresenius Vamed, and Corporate and Other. The Fresenius Medical Care segment comprises of dialysis products and healthcare services. The Fresenius Kabi segment specializes in intravenous drugs, clinical nutrition, infusion therapy, medical devices, and transfusion technology. The Fresenius Helios focuses on the private hospital operations. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The Corporate and Other segment includes the holding activities. The company was founded by Eduard Fresenius in October 1912 and is headquartered in Bad Homburg, Germany.

Headlines

Fresenius SE & Co. KGaA ADR (FSNUY)
January 6, 2022 |  nasdaq.com
See More Headlines

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:FSNUY
CIK
N/A
Fax
N/A
Employees
311,269
Year Founded
1912

Sales & Book Value

Annual Sales
$41.44 billion
Cash Flow
$2.25 per share
Book Value
$13.36 per share

Profitability

Net Income
$1.95 billion
Pretax Margin
9.56%

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares
2,233,817,000
Free Float
N/A
Market Cap
$23.21 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
11/02/2021
Today
1/28/2022
Fiscal Year End
12/31/2022

Social Links


MarketRank

Overall MarketRank

2.48 out of 5 stars

Analyst Opinion: 3.3Community Rank: 4.1Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 2.5 5 -4 -3 -2 -1 -












Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) Frequently Asked Questions

Is Fresenius SE & Co. KGaA a buy right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA in the last year. There are currently 5 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Fresenius SE & Co. KGaA stock.
View analyst ratings for Fresenius SE & Co. KGaA
or view top-rated stocks.

How has Fresenius SE & Co. KGaA's stock price been impacted by COVID-19 (Coronavirus)?

Fresenius SE & Co. KGaA's stock was trading at $10.13 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, FSNUY shares have increased by 2.6% and is now trading at $10.39.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 9,500 shares, a decline of 76.3% from the December 31st total of 40,000 shares. Based on an average daily volume of 94,700 shares, the days-to-cover ratio is presently 0.1 days.
View Fresenius SE & Co. KGaA's Short Interest
.

How were Fresenius SE & Co. KGaA's earnings last quarter?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) announced its quarterly earnings results on Tuesday, November, 2nd. The company reported $0.22 EPS for the quarter. The firm had revenue of $10.99 billion for the quarter. Fresenius SE & Co. KGaA had a net margin of 4.69% and a trailing twelve-month return on equity of 6.88%.
View Fresenius SE & Co. KGaA's earnings history
.

How often does Fresenius SE & Co. KGaA pay dividends? What is the dividend yield for Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA announced a dividend on Wednesday, May 19th. Stockholders of record on Tuesday, May 25th will be given a dividend of $0.5164 per share on Thursday, June 3rd. This represents a dividend yield of 3.76%. The ex-dividend date is Monday, May 24th.
View Fresenius SE & Co. KGaA's dividend history
.

Is Fresenius SE & Co. KGaA a good dividend stock?

Fresenius SE & Co. KGaA pays an annual dividend of $0.18 per share and currently has a dividend yield of 1.73%. The dividend payout ratio of Fresenius SE & Co. KGaA is 19.36%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Fresenius SE & Co. KGaA will have a dividend payout ratio of 17.65% next year. This indicates that Fresenius SE & Co. KGaA will be able to sustain or increase its dividend.
View Fresenius SE & Co. KGaA's dividend history.

What price target have analysts set for FSNUY?

11 brokerages have issued 1 year target prices for Fresenius SE & Co. KGaA's shares. Their forecasts range from $13.36 to $13.36. On average, they expect Fresenius SE & Co. KGaA's share price to reach $13.36 in the next year. This suggests a possible upside of 28.6% from the stock's current price.
View analysts' price targets for Fresenius SE & Co. KGaA
or view top-rated stocks among Wall Street analysts.

Who are Fresenius SE & Co. KGaA's key executives?

Fresenius SE & Co. KGaA's management team includes the following people:
  • Stephan Sturm, President & Chief Executive Officer
  • Rachel Clare Empey, Chief Financial Officer
  • Sebastian Biedenkopf, Head-Legal & Human Resources Director
  • Rice Powell, Chief Executive Officer-Fresenius Medical Care
  • Francesco de Meo, Chief Executive Officer-Fresenius Helios

What is Fresenius SE & Co. KGaA's stock symbol?

Fresenius SE & Co. KGaA trades on the OTCMKTS under the ticker symbol "FSNUY."

How do I buy shares of Fresenius SE & Co. KGaA?

Shares of FSNUY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Fresenius SE & Co. KGaA's stock price today?

One share of FSNUY stock can currently be purchased for approximately $10.39.

How much money does Fresenius SE & Co. KGaA make?

Fresenius SE & Co. KGaA has a market capitalization of $23.21 billion and generates $41.44 billion in revenue each year. The company earns $1.95 billion in net income (profit) each year or $0.93 on an earnings per share basis.

How many employees does Fresenius SE & Co. KGaA have?

Fresenius SE & Co. KGaA employs 311,269 workers across the globe.

When was Fresenius SE & Co. KGaA founded?

Fresenius SE & Co. KGaA was founded in 1912.

What is Fresenius SE & Co. KGaA's official website?

The official website for Fresenius SE & Co. KGaA is www.fresenius.com.

Where are Fresenius SE & Co. KGaA's headquarters?

Fresenius SE & Co. KGaA is headquartered at Else-Kroner-Strasse 1, Bad Homburg 2M, 61352.

How can I contact Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA's mailing address is Else-Kroner-Strasse 1, Bad Homburg 2M, 61352. The company can be reached via phone at (496) 172-6080 or via email at [email protected].


This page was last updated on 1/28/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.